Literature DB >> 3263621

Unusual branch point selection involved in splicing of the alternatively processed Calcitonin/CGRP-I pre-mRNA.

G J Adema1, R A Bovenberg, H S Jansz, P D Baas.   

Abstract

To study splice site selection in alternative RNA processing we used the human Calcitonin/CGRP-I (CALC-I) gene. Expression of the CALC-I gene in thyroid C-cells results predominantly in calcitonin (CT) mRNA (containing exons 1 to 4) whereas CGRP-I mRNA (containing exons 1,2,3,5 and 6) is the exclusive product in particular nerve cells. We previously reported that a model precursor RNA containing the exon 3 to exon 5 region is predominantly processed into CGRP-I mRNA in vitro using nuclear extracts of three different cell types. To study CT specific processing in Hela cell nuclear extracts we have used precursor RNAs corresponding to the exon 3 to exon 4 region containing only CT specific processing signals. The results revealed the usage of a uridine residue 23 nucleotides upstream of the 3' splice site as the major site of lariat formation in CT specific splicing. The implications of this finding for the alternative, tissue specific processing of the CALC-I pre-mRNA and for branch point selection in general are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263621      PMCID: PMC338760          DOI: 10.1093/nar/16.20.9513

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  52 in total

1.  Splicing of messenger RNA precursors.

Authors:  P A Sharp
Journal:  Science       Date:  1987-02-13       Impact factor: 47.728

2.  Excision of an intact intron as a novel lariat structure during pre-mRNA splicing in vitro.

Authors:  B Ruskin; A R Krainer; T Maniatis; M R Green
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

3.  Lariat RNA's as intermediates and products in the splicing of messenger RNA precursors.

Authors:  R A Padgett; M M Konarska; P J Grabowski; S F Hardy; P A Sharp
Journal:  Science       Date:  1984-08-31       Impact factor: 47.728

4.  The 5' terminus of the RNA moiety of U1 small nuclear ribonucleoprotein particles is required for the splicing of messenger RNA precursors.

Authors:  A Krämer; W Keller; B Appel; R Lührmann
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

5.  Messenger RNA splicing in vitro: an excised intervening sequence and a potential intermediate.

Authors:  P J Grabowski; R A Padgett; P A Sharp
Journal:  Cell       Date:  1984-06       Impact factor: 41.582

6.  Splicing of adenovirus RNA in a cell-free transcription system.

Authors:  R A Padgett; S F Hardy; P A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

7.  Normal and mutant human beta-globin pre-mRNAs are faithfully and efficiently spliced in vitro.

Authors:  A R Krainer; T Maniatis; B Ruskin; M R Green
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

8.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

9.  Point mutations identify the conserved, intron-contained TACTAAC box as an essential splicing signal sequence in yeast.

Authors:  C J Langford; F J Klinz; C Donath; D Gallwitz
Journal:  Cell       Date:  1984-03       Impact factor: 41.582

10.  Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing.

Authors:  M G Rosenfeld; J J Mermod; S G Amara; L W Swanson; P E Sawchenko; J Rivier; W W Vale; R M Evans
Journal:  Nature       Date:  1983 Jul 14-20       Impact factor: 49.962

View more
  21 in total

1.  Mutational analysis of a plant branchpoint and polypyrimidine tract required for constitutive splicing of a mini-exon.

Authors:  Craig G Simpson; Graham Thow; Gillian P Clark; S Nikki Jennings; Jenny A Watters; John W S Brown
Journal:  RNA       Date:  2002-01       Impact factor: 4.942

2.  Crystal structure of a model branchpoint-U2 snRNA duplex containing bulged adenosines.

Authors:  J A Berglund; M Rosbash; S C Schultz
Journal:  RNA       Date:  2001-05       Impact factor: 4.942

3.  Role for Fox-1/Fox-2 in mediating the neuronal pathway of calcitonin/calcitonin gene-related peptide alternative RNA processing.

Authors:  Hua-Lin Zhou; Andrew P Baraniak; Hua Lou
Journal:  Mol Cell Biol       Date:  2006-11-13       Impact factor: 4.272

4.  Validation of an in vitro RNA processing system for CT/CGRP precursor mRNA.

Authors:  G J Cote; I N Nguyen; C J Lips; S M Berget; R F Gagel
Journal:  Nucleic Acids Res       Date:  1991-07-11       Impact factor: 16.971

5.  The 2-kilobase intron of the herpes simplex virus type 1 latency-associated transcript has a half-life of approximately 24 hours in SY5Y and COS-1 cells.

Authors:  Darby L Thomas; Martin Lock; Janice M Zabolotny; Bangalore R Mohan; Nigel W Fraser
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  Repression of prespliceosome complex formation at two distinct steps by Fox-1/Fox-2 proteins.

Authors:  Hua-Lin Zhou; Hua Lou
Journal:  Mol Cell Biol       Date:  2008-06-23       Impact factor: 4.272

7.  Three recognition events at the branch-site adenine.

Authors:  C C Query; S A Strobel; P A Sharp
Journal:  EMBO J       Date:  1996-03-15       Impact factor: 11.598

8.  Functional crosstalk between exon enhancers, polypyrimidine tracts and branchpoint sequences.

Authors:  M Buvoli; S A Mayer; J G Patton
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

9.  The 216-nucleotide intron of the E1A pre-mRNA contains a hairpin structure that permits utilization of unusually distant branch acceptors.

Authors:  K Chebli; R Gattoni; P Schmitt; G Hildwein; J Stevenin
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

10.  Both U2 snRNA and U12 snRNA are required for accurate splicing of exon 5 of the rat calcitonin/CGRP gene.

Authors:  James R Roesser
Journal:  RNA       Date:  2004-08       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.